RedHill Biopharma Regains Rights to its Proprietary Bowel Preparation RHB-106 TEL-AVIV, Israel and RALEIGH, N.C., Jan. 02, 2020 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty...

RedHill Biopharma Reports 2013 Fourth Quarter and Year-End Financial Results 2013 Key Highlights Include: Strong cash position of over $34 million, as of February 2014, following two private placements in early 2014 and the exercise of warrants, including by directors...